Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SRD174 (Nalmefene) Cream for Pruritus in Atopic Dermatitis
NCT00838708Phase 2Completed
- Sponsor
- Serentis
- Start
- Jan 2009
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nalmefene in pruritus, atopic dermatitis (AD), sponsored by Serentis. Started Jan 2009; status: completed.
02
Drugs
nalmefene
03
Conditions
pruritusatopic dermatitis (AD)
Beyond the preview
Go deeper on NCT00838708.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00838708.